3LBA CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC). (September 2015)
- Record Type:
- Journal Article
- Title:
- 3LBA CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC). (September 2015)
- Main Title:
- 3LBA CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)
- Authors:
- Sharma, P.
Escudier, B.
McDermott, D.F.
George, S.
Hammers, H.J.
Srinivas, S.
Tykodi, S.S.
Sosman, J.A.
Procopio, G.
Plimack, E.R.
Castellano, D.
Gurney, H.
Donskov, F.
Bono, P.
Wagstaff, J.
Gauler, T.C.
Ueda, T.
Xu, L.A.
Waxman, I.M.
Motzer, R.J. - Abstract:
- Is Part Of:
- European journal of cancer. Volume 51:(2015)Supplement 3
- Journal:
- European journal of cancer
- Issue:
- Volume 51:(2015)Supplement 3
- Issue Display:
- Volume 51, Issue 3 (2015)
- Year:
- 2015
- Volume:
- 51
- Issue:
- 3
- Issue Sort Value:
- 2015-0051-0003-0000
- Page Start:
- S708
- Page End:
- Publication Date:
- 2015-09
- Subjects:
- Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0959-8049(16)31926-8 ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 2023.xml